United Kingdom

Krystal Biotech Inc (KRYS.OQ)

KRYS.OQ on NASDAQ Stock Exchange Capital Market

8 Dec 2017
Change (% chg)

-- (--)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Select another date:

Mon, Nov 13 2017

BRIEF-Krystal Biotech reports qtrly loss per share $1.26‍​

* Krystal Biotech reports that KB103 received clearance from RAC review and announces third quarter 2017 financial results

BRIEF-Krystal Biotech says KB103 granted orphan drug designation by FDA

* Krystal Biotech’s KB103 granted orphan drug designation by the FDA to treat patients with dystrophic epidermolysis bullosa

Select another date: